28451395|t|Association of COL4A3 (rs55703767), MMP-9 (rs17576) and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes
28451395|a|Type 2 diabetes (T2D) is defined by high levels of glucose in the blood. The collagen IV level is associated with conditions of hyperglycemia and insulin resistance. Collagen type IV α3 chain (COL4A3) is a structural protein of the extracellular matrix (ECM). Matrix metallopeptidase 9 (MMP-9) is an enzyme that degrades the extracellular matrix and its activity is moderated by TIMP metallopeptidase inhibitor 1 (TIMP-1). The aim of the current study was to examine the association between genetic polymorphisms of COL4A3 (rs55703767), MMP-9 (rs17576) and TIMP-1 (rs6609533) in patients with T2D. This case-control study was performed on 120 Iranian patients with T2D and 120 healthy individuals. Genotypes were analyzed using the amplification refractory mutation system-polymerase chain reaction technique. The findings demonstrated significant differences between genotypic and allelic distributions of COL4A3 (G / T) and MMP-9 (A / G) polymorphisms as follows: COL4A3 (G / T); TT vs. GG, odds ratio (OR)=0.235, 95% confidence interval (CI)=0.063-0.0802 (P=0.013) and T vs. G, OR =0.592, 95% CI =0.371-0.943 (P=0.026); MMP-9 (A / G); A G vs. GG, OR =2.429, 95% CI =1.232-4.820 (P=0.008) and A vs. G, OR =2.176, 95% CI =1.155-4.130 (P=0.013). No significant association was identified between TIMP-1 (A / G) polymorphism and T2D in females and males. Thus, the genotypic and allelic distributions of COL4A3 (G / T) and MMP-9 (A / G) polymorphisms were associated with T2D. In addition, no significant association was identified in the genotypic distribution of the TIMP-1 (A / G) gene in females and in males. Further studies in other ethnic groups are required to confirm these findings.
28451395	0	11	Association	T080	C0439849
28451395	15	34	COL4A3 (rs55703767)	T028	C1332774
28451395	36	51	MMP-9 (rs17576)	T028	C1334523
28451395	56	74	TIMP-1 (rs6609533)	T028	C1367459
28451395	75	93	gene polymorphisms	T045	C0678951
28451395	99	113	susceptibility	T201	C0012655
28451395	117	132	type 2 diabetes	T047	C0011860
28451395	133	148	Type 2 diabetes	T047	C0011860
28451395	150	153	T2D	T047	C0011860
28451395	174	191	levels of glucose	T034	C0428548
28451395	199	204	blood	T031	C0005767
28451395	210	221	collagen IV	T116,T123	C0009333
28451395	222	227	level	T080	C0441889
28451395	231	246	associated with	T080	C0332281
28451395	247	257	conditions	T080	C0348080
28451395	261	274	hyperglycemia	T047	C0020456
28451395	279	297	insulin resistance	T046	C0021655
28451395	299	333	Collagen type IV α3 chain (COL4A3)	T116,T129	C1314894
28451395	339	357	structural protein	T116,T123	C0582263
28451395	365	385	extracellular matrix	T024	C0015350
28451395	387	390	ECM	T024	C0015350
28451395	393	418	Matrix metallopeptidase 9	T116,T126	C0165519
28451395	420	425	MMP-9	T116,T126	C0165519
28451395	433	439	enzyme	T116,T126	C0014442
28451395	445	453	degrades	T169	C0243125
28451395	458	478	extracellular matrix	T024	C0015350
28451395	487	495	activity	T044	C0243102
28451395	512	545	TIMP metallopeptidase inhibitor 1	T116,T123	C0145947
28451395	547	553	TIMP-1	T116,T123	C0145947
28451395	604	615	association	T080	C0439849
28451395	624	645	genetic polymorphisms	T045	C0032529
28451395	649	668	COL4A3 (rs55703767)	T028	C1332774
28451395	670	685	MMP-9 (rs17576)	T028	C1334523
28451395	690	708	TIMP-1 (rs6609533)	T028	C1367459
28451395	712	720	patients	T101	C0030705
28451395	726	729	T2D	T047	C0011860
28451395	736	754	case-control study	T062	C0007328
28451395	776	783	Iranian	T098	C1553355
28451395	784	792	patients	T101	C0030705
28451395	798	801	T2D	T047	C0011860
28451395	810	829	healthy individuals	T098	C0237401
28451395	831	840	Genotypes	T032	C0017431
28451395	846	941	analyzed using the amplification refractory mutation system-polymerase chain reaction technique	T059	C2732542
28451395	947	955	findings	T169	C2607943
28451395	981	992	differences	T080	C1705242
28451395	1001	1010	genotypic	T032	C0017431
28451395	1015	1022	allelic	T028	C0002085
28451395	1023	1036	distributions	T169	C1704711
28451395	1040	1046	COL4A3	T028	C1332774
28451395	1048	1049	G	T114	C0018321
28451395	1052	1053	T	T114,T123	C0040087
28451395	1059	1064	MMP-9	T028	C1334523
28451395	1066	1067	A	T114,T123	C0001407
28451395	1070	1071	G	T114	C0018321
28451395	1073	1086	polymorphisms	T045	C0678951
28451395	1099	1105	COL4A3	T028	C1332774
28451395	1107	1108	G	T114	C0018321
28451395	1111	1112	T	T114,T123	C0040087
28451395	1115	1117	TT	T114,T123	C0040087
28451395	1122	1124	GG	T114	C0018321
28451395	1126	1136	odds ratio	T081	C0028873
28451395	1138	1140	OR	T081	C0028873
28451395	1153	1172	confidence interval	T081	C0009667
28451395	1174	1176	CI	T081	C0009667
28451395	1205	1206	T	T114,T123	C0040087
28451395	1211	1212	G	T114	C0018321
28451395	1214	1216	OR	T081	C0028873
28451395	1229	1231	CI	T081	C0009667
28451395	1256	1261	MMP-9	T028	C1334523
28451395	1263	1264	A	T114,T123	C0001407
28451395	1267	1268	G	T114	C0018321
28451395	1271	1272	A	T114,T123	C0001407
28451395	1273	1274	G	T114	C0018321
28451395	1279	1281	GG	T114	C0018321
28451395	1283	1285	OR	T081	C0028873
28451395	1298	1300	CI	T081	C0009667
28451395	1328	1329	A	T114,T123	C0001407
28451395	1334	1335	G	T114	C0018321
28451395	1337	1339	OR	T081	C0028873
28451395	1352	1354	CI	T081	C0009667
28451395	1379	1393	No significant	T033	C3694175
28451395	1394	1405	association	T080	C0439849
28451395	1410	1420	identified	T080	C0205396
28451395	1429	1435	TIMP-1	T028	C1367459
28451395	1437	1438	A	T114,T123	C0001407
28451395	1441	1442	G	T114	C0018321
28451395	1444	1456	polymorphism	T045	C0678951
28451395	1461	1464	T2D	T047	C0011860
28451395	1468	1475	females	T098	C0043210
28451395	1480	1485	males	T098	C0025266
28451395	1497	1506	genotypic	T032	C0017431
28451395	1511	1518	allelic	T028	C0002085
28451395	1519	1532	distributions	T169	C1704711
28451395	1536	1542	COL4A3	T028	C1332774
28451395	1544	1545	G	T114	C0018321
28451395	1548	1549	T	T114,T123	C0040087
28451395	1555	1560	MMP-9	T028	C1334523
28451395	1562	1563	A	T114,T123	C0001407
28451395	1566	1567	G	T114	C0018321
28451395	1569	1582	polymorphisms	T045	C0678951
28451395	1588	1603	associated with	T080	C0332281
28451395	1604	1607	T2D	T047	C0011860
28451395	1622	1636	no significant	T033	C3694175
28451395	1637	1648	association	T080	C0439849
28451395	1653	1663	identified	T080	C0205396
28451395	1671	1680	genotypic	T032	C0017431
28451395	1681	1693	distribution	T169	C1704711
28451395	1701	1707	TIMP-1	T028	C1367459
28451395	1709	1710	A	T114,T123	C0001407
28451395	1713	1714	G	T114	C0018321
28451395	1716	1720	gene	T028	C0017337
28451395	1724	1731	females	T098	C0043210
28451395	1739	1744	males	T098	C0025266
28451395	1771	1784	ethnic groups	T098	C0015031
28451395	1815	1823	findings	T169	C2607943